Entering text into the input field will update the search result below

22nd Century Group invests in Panacea Life Sciences

Dec. 04, 2019 10:17 AM ET22nd Century Group, Inc. (XXII) StockXXIIBy: Vandana Singh, SA News Editor2 Comments
  • 22nd Century Group (XXII +2%) closed an investment in Panacea Life Sciences, a developer and producer of legal, THC-free, hemp-derived cannabinoid products.
  • 22nd Century’s investments in Panacea over the next 12 -18 months are expected to total $24M.
  • The company also received a warrant to purchase preferred stock of Panacea, which upon full exercise will provide 22nd Century with a controlling equity position in Panacea.

Recommended For You

About XXII Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
XXII--
22nd Century Group, Inc.